首页> 外文期刊>Neurosurgical focus >A comparative effectiveness study of patient-rated and radiographic outcome after 2 types of decompression with fusion for spondylotic myelopathy: Anterior cervical discectomy versus corpectomy
【24h】

A comparative effectiveness study of patient-rated and radiographic outcome after 2 types of decompression with fusion for spondylotic myelopathy: Anterior cervical discectomy versus corpectomy

机译:患者额定减压后患者额定和射线照相结果的比较有效性研究与脊柱肌钙分离的融合:前宫颈椎间盘切除术与核心术

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Object: Both anterior cervical discectomy with fusion (ACDF) and anterior cervical corpectomy with fusion (ACCF) are used to treat cervical spondylotic myelopathy; however, there is currently no evidence for the superiority of one over the other in terms of patient-rated outcomes. This comparative effectiveness study compared the patientrated and radiographic outcomes of 2-level ACDF versus 1-level ACCF. Methods. This single-center study was nested within the EuroSpine Spine Tango data acquisition system. Inclusion criteria were the following: consecutive patients presenting with signs of cervical spondylotic myelopathy who underwent 2-level ACDF or 1-level ACCF between 2004 and 2011. Before and 12 months after surgery, patients completed the multidimensional Core Outcome Measures Index (COMI) and also rated global treatment outcome and satisfaction with care on 5-point Likert scales. Cervical lordosis, segmental height, and fusion rate were assessed radiographically before and immediately after surgery and at the last follow-up (20.4 ± 13.7 months, mean ± SD). Results. In total, 118 consecutive patients (80 in the ACDF group and 38 in the ACCF group) were included. Age, sex, comorbidity, baseline symptoms, baseline radiographic data, operation duration, and complication rates did not differ significantly between the 2 groups. Blood loss was significantly (p < 0.04) lower in the ACDF group. Postoperative mean segmental height was significantly (p = 0.0006) greater for ACDF (42.0 ± 4.2 mm, mean ± SD) than for ACCF (39.0 ± 4.0 mm), and global average lordosis improved to a significantly (p = 0.003) greater extent in ACDF (by 1.6° ± 4.1°) than in ACCF (by -1.0° ± 4.0°). Fusion rates for ACDF were 97.5% and for ACCF were 94.7% (p = 0.59). The 12-month patient-rated outcomes did not differ significantly between ACDF and ACCF: 82.4% and 68.6% had a good global outcome (operation helped/helped a lot) (p = 0.10), 86.5% and 82.9% were satisfied/ very satisfied with care (p = 0.62), and the reduction in the multidimensional COMI was 2.8 ± 2.7 and 2.2 ± 3 points (p = 0.30), respectively. The postoperative increase in lordosis angle showed low but significant correlations with the improvement in arm pain (r = 0.25, p = 0.014), highest pain (r = 0.25, p = 0.013), and function (r = 0.24, p = 0.016). Conclusions. Both ACDF and ACCF are safe and effective in the treatment of cervical spondylotic myelopathy, indicated by similarly good patient-rated outcomes 1 year after surgery. This precludes any conclusions regarding the superiority of one technique over the other, although it should be noted that ACDF resulted in less blood loss and greater improvements in cervical lordosis and segmental height than ACCF. Patients with improved lordosis angle had a better clinical outcome.
机译:目的:用融合(ACDF)和融合(ACCF)的前宫颈切除术既用于治疗宫颈脊髓型骨髓病;但是,就患者评级结果而言,目前没有证据表明一方的优势。这种比较有效性研究比较了2级ACDF的患者和射线照相结果与1级ACCF。方法。该单中心研究嵌套在Eutospine Spine Tango数据采集系统内。纳入标准如下:连续患者患有宫颈脊髓灰质肌片的迹象,在2004年和2011年之间进行2级ACDF或1级ACCF。手术后12个月,患者完成了多维核心结果指标指数(COMI)和在5点李克特级别的小心中也是额定全球治疗结果和满意度。颈椎病,节段高度和融合率在手术前和紧接在手术后和最后一次随访(20.4±13.7个月,平均±SD)进行评估。结果。总共包括118名连续患者(ACDF集团80人和ACCF集团中的38名)。年龄,性别,合并,基线症状,基线放射线数据,操作持续时间和并发症率在2组之间没有显着差异。 ACDF组中血液损失显着(P <0.04)。术后平均分高度显着(P = 0.0006)对于ACDF(42.0±4.2mm,平均值±SD)而不是用于ACCF(39.0±4.0mm),并且全球平均脊柱增强程度显着改善(p = 0.003) ACDF(1.6°±4.1°)比ACCF(通过-1.0°±4.0°)。 ACDF的融合率为97.5%,对于ACCF为94.7%(P = 0.59)。 ACDF和ACCF之间的12个月患者额定结果没有显着差异:82.4%和68.6%具有良好的全球结果(操作帮助/帮助了很多)(P = 0.10),满足/非常满足86.5%和82.9%对护理感到满意(P = 0.62),多维COMI的减少分别为2.8±2.7和2.2±3分(P = 0.30)。术语术后增长术语的垂直增长与臂疼痛的改善(r = 0.25,p = 0.014),最高疼痛(r = 0.25,p = 0.013),和功能(r = 0.24,p = 0.016) 。结论。 ACDF和ACCF在治疗宫颈脊柱型Myelopathy的治疗中是安全的,并且在手术后1年的同样良好的患者额定结果表明。这排除了对另一个技术的优越性的任何结论,尽管应该指出的是,ACDF导致患有损失程度较少,宫颈脊柱病症和节段高度的提高比ACC。改善脊髓源性的患者具有更好的临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号